Skip to main content
ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
252.93
+0.06 (0.02%)
At close: Mar 9, 2026, 4:00 PM EDT
252.93
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:05 PM EDT

ResMed Revenue

ResMed had revenue of $1.42B in the quarter ending December 31, 2025, with 10.98% growth. This brings the company's revenue in the last twelve months to $5.40B, up 9.57% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.

Revenue (ttm)
$5.40B
Revenue Growth
+9.57%
P/S Ratio
6.79
Revenue / Employee
$540,894
Employees
9,980
Market Cap
36.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medline 28.43B
Becton, Dickinson and Company 21.92B
Baxter International 11.24B
Alcon 10.40B
Intuitive Surgical 10.06B
Solventum 8.33B
The Cooper Companies 4.15B
Hologic 4.13B
Revenue Rankings

RMD News

More News